Tobacco nicotine promotes TRAIL resistance in lung cancer through SNHG5

Tobacco nicotine use is carcinogenic and a well-known risk factor for lung cancer. However, whether tobacco nicotine can induce drug resistance in lung cancer is not clear. The objective of the present study was to identify the TNF-related apoptosis-inducing ligand (TRAIL) resistance of long noncodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xin, Xu, Juan, Sheng, Xiaoan, Wang, Chao, Dong, Juanjuan, Shi, Xianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947578/
https://www.ncbi.nlm.nih.gov/pubmed/36845946
http://dx.doi.org/10.3892/etm.2023.11830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947578/
https://www.ncbi.nlm.nih.gov/pubmed/36845946
http://dx.doi.org/10.3892/etm.2023.11830

Ejemplares similares